{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:29:53Z","timestamp":1792074593774,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.clbc.2015.07.002","type":"journal-article","created":{"date-parts":[[2015,7,10]],"date-time":"2015-07-10T09:11:28Z","timestamp":1436519488000},"page":"399-402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Paradigm Shift in Axillary Breast Cancer Treatment; From \u201cTreat All-Except,\u201d Toward \u201cTreat None-Unless\u201d"],"prefix":"10.1016","volume":"15","author":[{"given":"Ingrid","family":"van den Hoven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri C.","family":"Voogd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudi M.H.","family":"Roumen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2015.07.002_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/(SICI)1096-9098(199606)62:2<75::AID-JSO1>3.0.CO;2-N","article-title":"Sentinel lymphadenectomy in primary breast carcinoma: An alternative to routine axillary dissection","volume":"62","author":"Giuliano","year":"1996","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.clbc.2015.07.002_bib2","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0140-6736(97)01004-0","article-title":"Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes","volume":"349","author":"Veronesi","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2015.07.002_bib3","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00000658-199904000-00013","article-title":"Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?","volume":"229","author":"Chu","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.clbc.2015.07.002_bib4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","article-title":"Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: The American College of Surgeons Oncology Group Z0011 randomized trial","volume":"252","author":"Giuliano","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.clbc.2015.07.002_bib5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2015.07.002_bib6","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2015.07.002_bib7","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1245\/ASO.2003.03.015","article-title":"A\u00a0nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy","volume":"10","author":"Van Zee","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2015.07.002_bib8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.amjsurg.2005.06.008","article-title":"Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram","volume":"190","author":"Degnim","year":"2005","journal-title":"Am J Surg"},{"key":"10.1016\/j.clbc.2015.07.002_bib9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/bjs.5943","article-title":"A\u00a0model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive","volume":"95","author":"Pal","year":"2008","journal-title":"Br J Surg"},{"key":"10.1016\/j.clbc.2015.07.002_bib10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2407-8-66","article-title":"New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients","volume":"8","author":"Kohrt","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clbc.2015.07.002_bib11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1245\/ASO.2003.05.020","article-title":"Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer","volume":"10","author":"Hwang","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2015.07.002_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10549-004-5781-z","article-title":"An axilla scoring\u00a0system to predict non-sentinel lymph node status in breast cancer patients\u00a0with sentinel lymph node involvement","volume":"91","author":"Barranger","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2015.07.002_bib13","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/bjs.7186","article-title":"Value of\u00a0Memorial Sloan-Kettering Cancer Center nomogram in clinical decision making\u00a0for sentinel lymph node-positive breast cancer","volume":"97","author":"van den Hoven","year":"2010","journal-title":"Br J Surg"},{"key":"10.1016\/j.clbc.2015.07.002_bib14","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1200\/JCO.2008.19.7418","article-title":"Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study","volume":"27","author":"Coutant","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2015.07.002_bib15","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1093\/jnci\/djs455","article-title":"International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer","volume":"104","author":"Meretoja","year":"2012","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2015.07.002_bib16","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1245\/s10434-006-9331-2","article-title":"Validation and limitations of use of a\u00a0breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy","volume":"14","author":"Alran","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2015.07.002_bib17","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1177\/000313480407001119","article-title":"Use and limitations of a nomogram predicting the likelihood of non-sentinel node involvement after a positive sentinel node biopsy in breast cancer patients","volume":"70","author":"Kocsis","year":"2004","journal-title":"Am Surg"},{"key":"10.1016\/j.clbc.2015.07.002_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.suronc.2011.12.001","article-title":"Multicentre validation of different predictive tools of non-sentinel lymph node involvement in breast cancer","volume":"21","author":"Cserni","year":"2012","journal-title":"Surg Oncol"},{"key":"10.1016\/j.clbc.2015.07.002_bib19","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1245\/s10434-011-2169-2","article-title":"High intersystem variability for the prediction of additional axillary non-sentinel lymph node involvement in individual patients with sentinel node-positive breast cancer","volume":"19","author":"van den Hoven","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2015.07.002_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2559.2002.14691.x","article-title":"Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. C. W. Elston & I. O. Ellis. Histopathology 1991; 19; 403-410","volume":"41","author":"Elston","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.clbc.2015.07.002_bib21","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1053\/ejso.2002.1268","article-title":"A\u00a0prospective validated model for predicting axillary node metastases based on 2,000 sentinel node procedures: the role of tumour location [corrected]","volume":"28","author":"Bevilacqua","year":"2002","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2015.07.002_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejso.2009.05.007","article-title":"Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study","volume":"36","author":"Gur","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2015.07.002_bib23","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1200\/JCO.2008.19.5750","article-title":"Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer","volume":"27","author":"Bilimoria","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2015.07.002_bib24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ejso.2012.04.018","article-title":"The post ACOSOG Z0011 era: does our new understanding of breast cancer really change clinical practice?","volume":"38","author":"G\u00fcth","year":"2012","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2015.07.002_bib25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1245\/s10434-014-4071-1","article-title":"The role of ultrasound-guided lymph node biopsy in axillary staging of invasive breast cancer in the post-ACOSOG Z0011 trial era","volume":"22","author":"Verheuvel","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2015.07.002_bib26","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/ans.12388","article-title":"Relevance of the American College of Surgeons Oncology Group Z0011 trial to breast cancer in the Australian setting","volume":"83","author":"Ngui","year":"2013","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.clbc.2015.07.002_bib27","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1200\/JCO.2007.11.9479","article-title":"Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer","volume":"26","author":"Katz","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2015.07.002_bib28","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1245\/s10434-006-9107-8","article-title":"Predicting patients at low probability of requiring postmastectomy radiation therapy","volume":"14","author":"Chagpar","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2015.07.002_bib29","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s10549-013-2468-3","article-title":"International multicenter tool to predict the risk of four or more tumor-positive axillary lymph nodes in breast cancer patients with sentinel node macrometastases","volume":"138","author":"Meretoja","year":"2013","journal-title":"Breast Cancer Res Treat"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820915001482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820915001482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:14:37Z","timestamp":1761513277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820915001482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1526820915001482"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2015.07.002","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Paradigm Shift in Axillary Breast Cancer Treatment; From \u201cTreat All-Except,\u201d Toward \u201cTreat None-Unless\u201d","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2015.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}